secwatch.observer — SEC 8-K summary
======================================

Issuer:     Absci Corp (ABSI)
CIK:        0001672688
Form:       8-K
Filed at:   2025-07-25T23:59:59+00:00
Accession:  0001193125-25-165466
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Absci prices $50M public offering of 16.67M shares at $3.00 per share
---------------------------------------------------------------------

- Offering of 16,670,000 shares at $3.00 per share; gross proceeds ~$50M.
- Net proceeds estimated at ~$46.7M (or ~$53.7M if underwriters' option exercised in full).
- Proceeds to fund internal programs, Integrated Drug Creation platform, and general corporate purposes.
- Underwriters: Morgan Stanley, J.P. Morgan, Jefferies, TD Securities; expected close July 28, 2025.
- Offer made under effective shelf registration statement on Form S-3 (File No. 333-267043).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1672688/000119312525165466/0001193125-25-165466-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1672688/000119312525165466/d65613d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-165466

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer